Company Update DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Regarding CTO 3 And FTO SEZ PU2 BSE India Intimation regarding: a) completion of GMP inspection by USFDA of our API facility at Bollaram (CTO3) with zero observations and b) receipt of EIR for closure of the USFDA inspection conducted at FTO SEZ PU2